comparemela.com
  1. Home
  2. Live Updates
  3. Vistagen Therapeutics Stock - Breaking News

Latest Breaking News On - Vistagen therapeutics stock - Page 1 : comparemela.com

Vistagen to Present at Stifel 2023 Healthcare Conference

08.11.2023 - Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous system (CNS) disorders, today announced that company .

Shawn singhVistagen therapeutics stock

Vistagen Provides Corporate Update and Reports Fiscal 2023 Third Quarter Financial Results

07.02.2023 - Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (CNS) disorders, today provided a corporate update .

United statesCompany phasePherin pharmaceuticalsDrug administrationAcquisition of pherin pharmaceuticals incExchange commissionInternational number tollPherin pharmaceuticals incLiebowitz social anxiety scaleNew drugLabel studyFast trackProbenecid phaseQuarter financialDial in numberAnnual report

Vistagen to Participate in Upcoming Morgan Stanley and Baird Healthcare Conferences

09.09.2022 - Vistagen Therapeutics, Inc. (Nasdaq: VTGN) (Vistagen, the Company), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (CNS) .

New yorkUnited statesVistagen therapeutics stockVistagen therapeutics

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.